/Investor DB

Red Tree Venture — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

CARGO Therapeuticscargo-tx.cominFeb 2023

Launched by Samsara in partnership with CAR T pioneers, advancing a clinically validated CD22 CAR T for lymphoma.

BiotechSan Mateo, US

Gina Chapman(Executive Officer, Director)inAnup Radhakrishnan(Executive Officer)inCassandra Gianna Luca(Director)Jeffrey Walsh(Director)Krishnan Viswanadhan(Director)

BoardAbraham Bassan(Director)

Board seatHeath Lukatch· per SEC Form D

Co-investorsNextech InvestSamsara BioCapitalWellington ManagementAlly Bridge GroupJanus Henderson InvestorsPerceptive Xontogeny Venture+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.